Maria Cristina Grò

Maria Cristina Grò

Auto-generated profile, based on publicly available information

Maria Cristina Grò

Laboratory of Virology, Istituto Superiore di Sanità, Rome, Italy

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 1991 in Virology
Verified
Journal Article
Closed access
CGColomba Giorgi
Colomba Giorgi
LALuisa Accardi
Luisa Accardi
LNLoredana Nicoletti
Loredana Nicoletti
MGMaria Cristina Gro
Maria Cristina Gro
KTKazuaki Takehara
Kazuaki Takehara
DBDavid H.L. Bishop
David H.L. Bishop

12 September 2005 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
MTM. T. Tebano
M. T. Tebano
AMAlberto Martire
Alberto Martire
NRN. Rebola
N. Rebola
RPR. Pepponi
R. Pepponi
MDM. R. Domenici
M. R. Domenici
PPP. Popoli
P. Popoli

14 March 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HOH. Ongun Onaran
H. Ongun Onaran
CACaterina Ambrosio
Caterina Ambrosio
ÖUÖzlem Uğur
Özlem Uğur
EKErzsebet Madaras Koncz
Erzsebet Madaras Koncz
MGMaria Cristina Grò
Maria Cristina Grò
TCTommaso Costa
Tommaso Costa
Discovering biased agonists requires a method that can reliably distinguish the bias in signalling due to unbalanced activation of diverse transduction proteins from that of differential amplification inherent to the system being studied, which invariably results from the non-linear nature of biological signalling networks and their measurement. We have systematically compared the performance of seven methods of bias diagnostics, all of which are based on the analysis of concentration-response curves of ligands according to classical receptor theory. We computed bias factors for a number of β-adrenergic agonists by comparing BRET assays of receptor-transducer interactions with Gs, Gi and arrestin. Using the same ligands, we also compared responses at signalling steps originated from the same receptor-transducer interaction, among which no biased efficacy is theoretically possible. In either case, we found a high level of false positive results and a general lack of correlation among methods. Altogether this analysis shows that all tested methods, including some of the most widely used in the literature, fail to distinguish true ligand bias from “system bias” with confidence. We also propose two novel semi quantitative methods of bias diagnostics that appear to be more robust and reliable than currently available strategies.

6 August 2015 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DMDavide Malfacini
Davide Malfacini
CACaterina Ambrosio
Caterina Ambrosio
MGM. C. Gro’
M. C. Gro’
MSM. Sbraccia
M. Sbraccia
CTClaudio Trapella
Claudio Trapella
GCG. Calo’
G. Calo’
Nociceptin/orphanin FQ (N/OFQ) controls several biological functions by selectively activating an opioid like receptor named N/OFQ peptide receptor (NOP). Biased agonism is emerging as an important and therapeutically relevant pharmacological concept in the field of G protein coupled receptors including opioids. To evaluate the relevance of this phenomenon in the NOP receptor, we used a bioluminescence resonance energy transfer technology to measure the interactions of the NOP receptor with either G proteins or β-arrestin 2 in the absence and in presence of increasing concentration of ligands. A large panel of receptor ligands was investigated by comparing their ability to promote or block NOP/G protein and NOP/arrestin interactions. In this study we report a systematic analysis of the functional selectivity of NOP receptor ligands. NOP/G protein interactions (investigated in cell membranes) allowed a precise estimation of both ligand potency and efficacy yielding data highly consistent with the known pharmacological profile of this receptor. The same panel of ligands displayed marked differences in the ability to promote NOP/β-arrestin 2 interactions (evaluated in whole cells). In particular, full agonists displayed a general lower potency and for some ligands an inverted rank order of potency was noted. Most partial agonists behaved as pure competitive antagonists of receptor/arrestin interaction. Antagonists displayed similar values of potency for NOP/Gβ1 or NOP/β-arrestin 2 interaction. Using N/OFQ as reference ligand we computed the bias factors of NOP ligands and a number of agonists with greater efficacy at G protein coupling were identified.

1 May 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
PMpaola molinari
paola molinari
CACaterina Ambrosio
Caterina Ambrosio
DRDaniela Riitano
Daniela Riitano
MSMaria Sbraccia
Maria Sbraccia
MGMaria Cristina Grò
Maria Cristina Grò
TCTommaso Costa
Tommaso Costa
Fusion proteins between heptahelical receptors (GPCR) and G protein α-subunits show enhanced signaling efficiency in transfected cells. This is believed to be the result of molecular proximity, because the interaction between linked modules of one protein chain, if not constrained by structure, should be strongly favored compared with the same in which partners react as free species. To test this assumption we made a series of fusion proteins (type 1 and 4 opioid receptors with Go and β2adrenergic and dopamine 1 receptors with GsL) and some mutated analogs carrying different tags and defective GPCR or Gα subunits. Using cotransfection experiments with readout protocols able to distinguish activation at fused and non-fused α-subunits, we found that both the GPCR and the Gα limb of one fusion protein can freely interact with non-fused proteins and the tethered partners of a neighboring fusion complex. Moreover, a bulky polyanionic inhibitor can suppress with identical potency receptor-Gα interaction, either when occurring between latched domains of a fused system or separate elements of distinct molecules, indicating that the binding surfaces are equally accessible in both cases. These data demonstrate that there is no entropy drive from the linked condition of fusion proteins and suggest that their signaling may result from the GPCR of one complex interacting with the α-subunit of another. Moreover, the enhanced coupling efficiency commonly observed for fusion proteins is not due to the receptor tether, but to the transmembrane helix that anchors Gα to the membrane.

1 February 1993 in Virus Research
Verified
Journal Article
Closed access
LALuisa Accardi
Luisa Accardi
MGMaria Cristina Grò
Maria Cristina Grò
PBPaola Di Bonito
Paola Di Bonito
CGColomba Giorgi
Colomba Giorgi